Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation

Behav Modif. 1994 Oct;18(4):470-87. doi: 10.1177/01454455940184005.

Abstract

Using a combination of an alternating treatment and double-blind placebo-controlled drug design, the independent and combined effects of two behavioral interventions and two doses of methylphenidate (MPH) in 3 children with Attention Deficit Hyperactivity Disorder (ADHD) and mental retardation (MR) were assessed. In this single subject design, 2 of the 3 subjects responded positively to medication as measured by increased on-task behavior. The first behavioral intervention, a token economy for on-task behavior, was ineffective for increasing either on-task behavior or work accuracy when combined with placebo. However, improvement in work accuracy was realized with implementation of a second behavioral intervention that specifically targeted accuracy independent of drug conditions. The current findings highlight both the positive effects and limitations of the two commonly used treatment modalities for ADHD. Future studies should continue to extend this area of investigative efforts to produce more data-based knowledge as to the appropriate doses of treatment, both pharmacological and behavioral, with children with both ADHD and mental retardation.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity / complications
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Attention Deficit Disorder with Hyperactivity / therapy*
  • Behavior Therapy*
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Double-Blind Method
  • Humans
  • Intellectual Disability / complications
  • Intellectual Disability / drug therapy
  • Intellectual Disability / therapy*
  • Methylphenidate / administration & dosage
  • Methylphenidate / therapeutic use*
  • Placebos
  • Students / psychology
  • Token Economy
  • Treatment Outcome

Substances

  • Placebos
  • Methylphenidate